Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Karyopharm Therapeutics Inc. buy Barclays PLC

Karyopharm Therapeutics Inc.
Start price
€0.54
13.05.25 / 50%
Target price
€9.00
13.05.26
Performance (%)
-
End price
-
14.05.26
Summary
This prediction was cancelled by the user.
Performance without dividends (%)
Name 1w 1m 1y
Karyopharm Therapeutics Inc. - - -
iShares Core DAX® -1,59 % 5,03 % 6,33 %
iShares Nasdaq 100 -4,15 % -0,13 % 25,73 %
iShares Nikkei 225® -6,30 % 0,53 % 41,38 %
iShares S&P 500 -3,23 % 0,47 % 20,45 %

Comments by Barclays_PLC for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -
Target price 9.003
Change
Ends at 13.05.26

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target raised by analysts at Barclays PLC from $5.00 to $10.00. They now have an "overweight" rating on the stock.
Ratings data for KPTI provided by MarketBeat

Barclays PLC 
0
Report Share
13.05.25
In the thread Trading Karyopharm Therapeutics Inc.
Prediction Buy
Perf. (%) -
Target price 9.003
Change
Ends at 13.05.26

Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten

Barclays PLC 
0
Report Share
14.05.26